Bridgewater Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Bridgewater Associates's OGN Position: Q1 2026 in Review
Bridgewater Associates reduced its Organon & Co (OGN) stake by 35% in Q1 2026, selling an estimated $2.37M and leaving 594,483 shares worth $3.56M. The position accounts for 0.02% of the portfolio, ranked #498.
Bridgewater Associates first reported a position in OGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.14M in Q3 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Bridgewater Associates held 594,483 shares of Organon & Co worth $3.56M as of Q1 2026.
- Bridgewater Associates sold 314,742 Organon & Co shares in Q1 2026, an estimated $2.37M.
- Organon & Co made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #498 holding.
- Bridgewater Associates first reported a position in Organon & Co in Q3 2024 and has held it in 7 quarters since.
- Bridgewater Associates's Organon & Co position peaked at $7.14M in Q3 2025.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.